News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,629 Results
Type
Article (87734)
Company Profile (824)
Press Release (778052)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91349)
Employer Resources (203)
FDA (18348)
Job Trends (17414)
News (397685)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (166)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18436)
Artificial intelligence (576)
Autoimmune disease (129)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (598)
Cancer (4620)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (780)
Cervical cancer (36)
Clinical research (76452)
Collaboration (1576)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (727)
Cystic fibrosis (147)
Data (5737)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (490)
Diagnostics (7161)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (266)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99874)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134457)
Executive appointments (1009)
FDA (21159)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1425)
Gene editing (201)
Generative AI (59)
Gene therapy (617)
GLP-1 (1081)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (271)
Immuno-oncology (34)
Indications (73)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (214)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (642)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (735)
MASH (164)
Medical device (14965)
Medtech (15004)
Mergers & acquisitions (22861)
Metabolic disorders (1277)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (320)
Neuropsychiatric disorders (85)
Neuroscience (2938)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (611)
Opinion (326)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (198)
Parkinson's disease (269)
Partnered (34)
Patents (463)
Patient recruitment (395)
Peanut (58)
People (66605)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23610)
Phase II (33186)
Phase III (25003)
Pipeline (3762)
Policy (318)
Postmarket research (3554)
Preclinical (10658)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (794)
Real estate (7435)
Recruiting (80)
Regulatory (28496)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (233)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1100)
Venture capital (76)
Weight loss (429)
Women's health (76)
Worklife (21)
Date
Today (67)
Last 7 days (668)
Last 30 days (2820)
Last 365 days (33386)
2025 (32165)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51288)
Australia (9013)
California (10736)
Canada (3146)
China (1038)
Colorado (453)
Connecticut (479)
Delaware (320)
Europe (117907)
Florida (1574)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (884)
India (62)
Indiana (517)
Iowa (22)
Japan (373)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7963)
Michigan (339)
Minnesota (623)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2937)
New Mexico (32)
New York (2874)
North Carolina (1526)
North Dakota (10)
Northern California (5049)
Ohio (326)
Oklahoma (22)
Oregon (52)
Pennsylvania (2178)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4122)
Tennessee (165)
Texas (1684)
United States (39091)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (904)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,629 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoff Tracker
Adare Shuts Down Philadelphia Plant, Leaving 137 Jobless
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
December 11, 2025
·
93 min read
·
BioSpace Editorial Staff
Obesity
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
December 11, 2025
·
3 min read
·
Annalee Armstrong
FDA
Opinion: FDA Is Built on Predictability and Expertise, Not Norm-Breaking
The FDA is becoming deeply compromised and increasingly at risk of being permanently transformed in ways contrary to its mission, history and culture.
December 11, 2025
·
5 min read
·
Steven Grossman
Breast cancer
Pfizer Builds Case for Tukysa as ‘New Standard Regimen’ in First-Line Metastatic Breast Cancer
While new late-stage data point to some liver toxicity signals, analysts at BMO Capital Markets said Tukysa’s efficacy outcomes “appear to more than make up for any safety concerns.”
December 11, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Zealand Bets Up To $2.5B in Metabolic Pact With Chinese Biotech
Also on Thursday, Zealand held its Capital Markets Day in London,
outlining the strategy
for its weight management franchise in the near-term, including launching five products by 2030.
December 11, 2025
·
2 min read
·
Tristan Manalac
Breast cancer
Roche’s Oral SERD Cuts Death Risk by 30% in Early-Stage Breast Cancer
While overall survival remains immature, results so far show a clear trend in favor of Roche’s giredestrant.
December 11, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Pfizer’s Cost Cuts Claim 200+ Jobs in Switzerland: Report
Pfizer is in the midst of an aggressive, multi-year cost-cutting effort, which so far has left nearly 2,000 people jobless.
December 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
December 11, 2025
·
9 min read
Press Releases
Lexicon Pharmaceuticals Announces Publication of Preclinical Data in the Journal of the Endocrine Society on Acyl-CoA Synthetase 5 (ACSL5) Reinforcing the Scientific Rationale for LX9851
December 11, 2025
·
5 min read
Press Releases
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
December 11, 2025
·
4 min read
1 of 86,663
Next
